PSA Screening for HIM Act

# PSA Screening for HIM Act Summary **What the Bill Would Do** The PSA Screening for HIM Act addresses prostate cancer screening by focusing on PSA (prostate-specific antigen) testing. PSA tests measure a protein produced by the prostate gland and are used to screen for prostate cancer in men. The bill appears designed to expand or modify coverage and access to PSA screening as part of preventive health care, though specific legislative details would determine whether it mandates coverage, removes restrictions, or changes how these tests are provided. **Who It Affects** This bill primarily affects men eligible for health coverage, particularly those in Medicare and potentially those with private insurance.

It could also impact healthcare providers, insurance companies, and public health policy around cancer prevention and screening guidelines. **Current Status** The bill (S. 297) was introduced in the 119th Congress by Senator John Boozman (R-AR) and remains in committee, meaning it has not yet been debated or voted on by the full Senate. Without further action, it will not become law in its current form.